Scott M Bolton1,2, Amir F Kagalwalla1,3, Nicoleta C Arva4, Ming-Yu Wang1, Katie Amsden1, Hector Melin-Aldana4, Evan S Dellon5, Paul J Bryce6,7, Barry K Wershil1, Joshua B Wechsler1,6. 1. Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. 2. Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. 3. Division of Gastroenterology, Department of Pediatrics, John H. Stroger, Jr. Hospital of Cook County, Chicago, Illinois, USA. 4. Department of Pathology, Ann & Robert H. Lurie Children's Hospital of Chicago, Illinois, USA. 5. Center for Esophageal Diseases and Swallowing, Division of Gastroenterology & Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA. 6. Division of Allergy & Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. 7. Current affiliation: Immunology & Inflammation Therapeutic Area, Sanofi, USA.
Abstract
OBJECTIVES: Mast cells (MCs) are increased in eosinophilic esophagitis (EoE). Endoscopic abnormalities, symptoms, and epithelial changes can persist after treatment despite a reduction of esophageal eosinophilia. It is unknown whether this could be due to persistent MC infiltration. We aimed to determine whether patients with histologically inactive (HI) EoE (defined as <15 eosinophils per high-powered field) with persistent symptoms, endoscopic, or epithelial abnormalities after treatment have increased MCs. METHODS: Secondary analysis of prospective data from 93 children with EoE undergoing post-treatment endoscopy between 2011 and 2015. Thirty-five non-EoE controls were included. Immunohistochemistry for tryptase, an MC marker, was performed on mid and distal esophageal biopsies. Total and degranulated intraepithelial MCs per high-powered field (MC/hpf) were quantified. Symptoms and endoscopic findings were recorded at time of endoscopy. MC/hpf were compared between HI-EoE and control, and among HI-EoE based on endoscopic and histologic findings, and symptoms. Nine clinical remission (CR) patients were identified, with absence of endoscopic abnormalities and symptoms. RESULTS: MC/hpf were increased in HI-EoE compared with control (17 ± 11 vs 8 ± 6, P < 0.0). Patients with persistent endoscopic abnormalities had increased total (20 ± 12 vs 13 ± 10, P = 0.001) and degranulated (8 ± 6 vs 5 ± 4, P = 0.002) MC/hpf, with no difference in eosinophils. MC/hpf predicted furrowing (odds ratio = 1.06, P = 0.01) and rings (odds ratio = 1.05, P = 0.03) after controlling for treatment type, proton-pump inhibitor, eosinophils, and duration of therapy. Patients with persistent basal zone hyperplasia and dilated intercellular spaces had increased MC/hpf. Eosinophils were weakly correlated with MC/hpf in the mid (r = 0.30, P < 0.001) and distal (r = 0.29, P < 0.001) esophagus. Clinical remission patients had lower MC/hpf compared with patients with persistent symptoms and/or endoscopic abnormalities. DISCUSSION: MC density is increased in patients with endoscopic and epithelial abnormalities, as well as a few symptoms, despite resolution of esophageal eosinophilia after treatment. This association warrants further study to ascertain whether MCs play an eosinophil independent role in EoE.
OBJECTIVES: Mast cells (MCs) are increased in eosinophilic esophagitis (EoE). Endoscopic abnormalities, symptoms, and epithelial changes can persist after treatment despite a reduction of esophageal eosinophilia. It is unknown whether this could be due to persistent MC infiltration. We aimed to determine whether patients with histologically inactive (HI) EoE (defined as <15 eosinophils per high-powered field) with persistent symptoms, endoscopic, or epithelial abnormalities after treatment have increased MCs. METHODS: Secondary analysis of prospective data from 93 children with EoE undergoing post-treatment endoscopy between 2011 and 2015. Thirty-five non-EoE controls were included. Immunohistochemistry for tryptase, an MC marker, was performed on mid and distal esophageal biopsies. Total and degranulated intraepithelial MCs per high-powered field (MC/hpf) were quantified. Symptoms and endoscopic findings were recorded at time of endoscopy. MC/hpf were compared between HI-EoE and control, and among HI-EoE based on endoscopic and histologic findings, and symptoms. Nine clinical remission (CR) patients were identified, with absence of endoscopic abnormalities and symptoms. RESULTS: MC/hpf were increased in HI-EoE compared with control (17 ± 11 vs 8 ± 6, P < 0.0). Patients with persistent endoscopic abnormalities had increased total (20 ± 12 vs 13 ± 10, P = 0.001) and degranulated (8 ± 6 vs 5 ± 4, P = 0.002) MC/hpf, with no difference in eosinophils. MC/hpf predicted furrowing (odds ratio = 1.06, P = 0.01) and rings (odds ratio = 1.05, P = 0.03) after controlling for treatment type, proton-pump inhibitor, eosinophils, and duration of therapy. Patients with persistent basal zone hyperplasia and dilated intercellular spaces had increased MC/hpf. Eosinophils were weakly correlated with MC/hpf in the mid (r = 0.30, P < 0.001) and distal (r = 0.29, P < 0.001) esophagus. Clinical remission patients had lower MC/hpf compared with patients with persistent symptoms and/or endoscopic abnormalities. DISCUSSION: MC density is increased in patients with endoscopic and epithelial abnormalities, as well as a few symptoms, despite resolution of esophageal eosinophilia after treatment. This association warrants further study to ascertain whether MCs play an eosinophil independent role in EoE.
Authors: Evan S Dellon; Xiaoxin Chen; C Ryan Miller; Karen J Fritchie; Tara C Rubinas; John T Woosley; Nicholas J Shaheen Journal: Am J Gastroenterol Date: 2010-10-26 Impact factor: 10.864
Authors: Ikuo Hirano; Nelson Moy; Michael G Heckman; Colleen S Thomas; Nirmala Gonsalves; Sami R Achem Journal: Gut Date: 2012-05-22 Impact factor: 23.059
Authors: Amir F Kagalwalla; Joshua B Wechsler; Katie Amsden; Sally Schwartz; Melanie Makhija; Anthony Olive; Carla M Davis; Maria Manuel-Rubio; Seth Marcus; Ronda Shaykin; Maureen Sulkowski; Kristen Johnson; Jessica N Ross; Mary Ellen Riffle; Marion Groetch; Hector Melin-Aldana; Deborah Schady; Hannah Palac; Kwan-Youn A Kim; Barry K Wershil; Margaret H Collins; Mirna Chehade Journal: Clin Gastroenterol Hepatol Date: 2017-06-08 Impact factor: 11.382
Authors: Scott Pentiuk; Phillip E Putnam; Margaret H Collins; Marc E Rothenberg Journal: J Pediatr Gastroenterol Nutr Date: 2009-02 Impact factor: 2.839
Authors: Joshua B Wechsler; Scott M Bolton; Katie Amsden; Barry K Wershil; Ikuo Hirano; Amir F Kagalwalla Journal: Clin Gastroenterol Hepatol Date: 2017-12-15 Impact factor: 11.382
Authors: Kelly A Whelan; Bridget C Godwin; Benjamin Wilkins; Okan U Elci; Alain Benitez; Maureen DeMarshall; Medha Sharma; Jonathan Gross; Andres J Klein-Szanto; Chris A Liacouras; Evan S Dellon; Jonathan M Spergel; Gary W Falk; Amanda B Muir; Hiroshi Nakagawa Journal: Clin Gastroenterol Hepatol Date: 2019-09-06 Impact factor: 11.382
Authors: Evan S Dellon; Paneez Khoury; Amanda B Muir; Chris A Liacouras; Ekaterina Safroneeva; Dan Atkins; Margaret H Collins; Nirmala Gonsalves; Gary W Falk; Jonathan M Spergel; Ikuo Hirano; Mirna Chehade; Alain M Schoepfer; Calies Menard-Katcher; David A Katzka; Peter A Bonis; Albert J Bredenoord; Bob Geng; Elizabeth T Jensen; Robert D Pesek; Paul Feuerstadt; Sandeep K Gupta; Alfredo J Lucendo; Robert M Genta; Girish Hiremath; Emily C McGowan; Fouad J Moawad; Kathryn A Peterson; Marc E Rothenberg; Alex Straumann; Glenn T Furuta; Seema S Aceves Journal: J Allergy Clin Immunol Date: 2022-05-20 Impact factor: 14.290
Authors: Evan S Dellon; Paneez Khoury; Amanda B Muir; Chris A Liacouras; Ekaterina Safroneeva; Dan Atkins; Margaret H Collins; Nirmala Gonsalves; Gary W Falk; Jonathan M Spergel; Ikuo Hirano; Mirna Chehade; Alain M Schoepfer; Calies Menard-Katcher; David A Katzka; Peter A Bonis; Albert J Bredenoord; Bob Geng; Elizabeth T Jensen; Robert D Pesek; Paul Feuerstadt; Sandeep K Gupta; Alfredo J Lucendo; Robert M Genta; Girish Hiremath; Emily C McGowan; Fouad J Moawad; Kathryn A Peterson; Marc E Rothenberg; Alex Straumann; Glenn T Furuta; Seema S Aceves Journal: Gastroenterology Date: 2022-05-20 Impact factor: 33.883
Authors: Netali Ben-Baruch Morgenstern; Adina Y Ballaban; Ting Wen; Tetsuo Shoda; Julie M Caldwell; Kara Kliewer; Jennifer M Felton; J Pablo Abonia; Vincent A Mukkada; Philip E Putnam; Scott M Bolton; Daniel F Dwyer; Nora A Barrett; Marc E Rothenberg Journal: J Allergy Clin Immunol Date: 2022-03-15 Impact factor: 14.290
Authors: Evan S Dellon; Kathryn A Peterson; Joseph A Murray; Gary W Falk; Nirmala Gonsalves; Mirna Chehade; Robert M Genta; John Leung; Paneez Khoury; Amy D Klion; Sabine Hazan; Michael Vaezi; Adam C Bledsoe; Sandy R Durrani; Chao Wang; Camilla Shaw; Alan T Chang; Bhupinder Singh; Amol P Kamboj; Henrik S Rasmussen; Marc E Rothenberg; Ikuo Hirano Journal: N Engl J Med Date: 2020-10-22 Impact factor: 91.245
Authors: Evan S Dellon; Nirmala Gonsalves; Marc E Rothenberg; Ikuo Hirano; Mirna Chehade; Kathryn A Peterson; Gary W Falk; Joseph A Murray; Lauren T Gehman; Alan T Chang; Bhupinder Singh; Henrik S Rasmussen; Robert M Genta Journal: Clin Gastroenterol Hepatol Date: 2021-06-02 Impact factor: 11.382
Authors: Craig C Reed; Robert M Genta; Bradford A Youngblood; Joshua B Wechsler; Evan S Dellon Journal: Clin Gastroenterol Hepatol Date: 2020-08-12 Impact factor: 13.576
Authors: Kevin Tom; Bhaven K Mehta; Aileen Hoffmann; Kathleen Aren; Mary Carns; Jungwha Lee; Viktor Martyanov; Dillon Popovich; Noelle Kosarek; Tammara Wood; Darren Brenner; Dustin A Carlson; Lorena Ostilla; Emma Willcocks; Paul Bryce; Joshua B Wechsler; Michael L Whitfield; Monique Hinchcliff Journal: J Scleroderma Relat Disord Date: 2020-07-27